Activation of MYC pathway is a unifying pathological event in the progression from monoclonal gammopathy of undetermined significance (MGUS) to myeloma (MM)

被引:0
|
作者
Chng, Wee J. [1 ]
Chesi, Marta [1 ]
Price-Troska, Tammy [2 ]
Ahmann, Greg [1 ]
Henderson, Kim [2 ]
Greipp, Philip [2 ]
Kyle, Robert [2 ]
Rajkumar, S. Vincent [2 ]
Gertz, Morie [2 ]
Fonseca, Rafael [1 ]
Bergsagel, P. Leif [1 ]
机构
[1] Mayo Clin, Scottsdale, AZ USA
[2] Mayo Clin, Dept Hematol, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
241
引用
收藏
页码:78A / 78A
页数:1
相关论文
共 50 条
  • [31] Presence of monoclonal free light chains in serum predicts risk of progression in monoclonal gammopathy of undetermined significance (MGUS).
    Rajkumar, SV
    Kyle, RA
    Therneau, TM
    Bradwell, AR
    Melton, LJ
    Katzmann, JA
    BLOOD, 2003, 102 (11) : 935A - 935A
  • [32] The role of mesenchymal stromal cells (MSC) in the development of monoclonal gammopathy of undetermined significance (MGUS) via smoldering multiple myeloma (SMM) to multiple myeloma (MM)
    Bogun, L.
    Koch, A.
    Scherer, B.
    Fenk, R.
    Maus, U.
    Twarock, S.
    Bormann, F.
    Koehrer, K.
    Petzsch, P.
    Wachtmeister, T.
    Schroeder, T.
    Jaeger, P.
    Geyh, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 88 - 88
  • [33] Longitudinal whole body MRI (wbMRI) in monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma
    Merz, Maximilian
    Wagner-Gund, Barbara
    Neben, Kai
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Hillengass, Jens
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)
    Matthew Ho
    Ashish Patel
    Chia Yin Goh
    Maria Moscvin
    Li Zhang
    Giada Bianchi
    Leukemia, 2020, 34 : 3111 - 3125
  • [35] THE PREVALENCE OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) AND ASYMPTOMATIC MULTIPLE MYELOMA (AMM) FOR HIGH RISK GROUPS
    Oner, I.
    Unal, A.
    Pala, C.
    Sivgin, S.
    Keklik, M.
    Patiroglu, T.
    Akyol, G.
    Cetin, M.
    Eser, B.
    HAEMATOLOGICA, 2013, 98 : 613 - 613
  • [36] Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)
    Ho, Matthew
    Patel, Ashish
    Goh, Chia Yin
    Moscvin, Maria
    Zhang, Li
    Bianchi, Giada
    LEUKEMIA, 2020, 34 (12) : 3111 - 3125
  • [37] INK4 ANALYSIS IN PLASMA CELLS, STROMAL AND ENDOTHELIAL CELLS FROM PATIENTS WITH MULTIPLE MYELOMA (MM) AND MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
    Gernone, Angela
    Di Pietro, Giulia
    Cirulli, Teresa
    Vacca, Angelo
    Dammacco, Franco
    ANNALS OF ONCOLOGY, 2004, 15 : 78 - 78
  • [38] Urinary Protein Levels in Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) Predict Severe Disease Related Complications at Myeloma Progression
    Belotti, Angelo
    Malagola, Michele
    Crippa, Claudia
    Prezioso, Ilaria
    Schieppati, Francesca
    Ribolla, Rossella
    Orlando, Vincenza
    Russo, Domenico
    Rossi, Giuseppe
    BLOOD, 2015, 126 (23)
  • [39] Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
    Geffen Kleinstern
    Dirk R. Larson
    Cristine Allmer
    Aaron D. Norman
    Grace Muntifering
    Jason Sinnwell
    Alissa Visram
    Vincent Rajkumar
    Angela Dispenzieri
    Robert A. Kyle
    Susan L. Slager
    Shaji Kumar
    Celine M. Vachon
    Blood Cancer Journal, 12
  • [40] Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
    Kleinstern, Geffen
    Larson, Dirk R.
    Allmer, Cristine
    Norman, Aaron D.
    Muntifering, Grace
    Sinnwell, Jason
    Visram, Alissa
    Rajkumar, Vincent
    Dispenzieri, Angela
    Kyle, Robert A.
    Slager, Susan L.
    Kumar, Shaji
    Vachon, Celine M.
    BLOOD CANCER JOURNAL, 2022, 12 (04)